Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Burden of Pretreatment HIV Drug Resistance in Trinidad and Tobago.

AIDS research and human retroviruses - 1 Apr 2024

Gbadamosi Semiu O, Boyce Gregory, Trepka Mary Jo, Edwards Robert Jeffrey

Abstract excerpt

Strategies to improve the scale-up of antiretroviral therapy (ART) for patients with HIV in Trinidad and Tobago, including the adoption of the "Test and Treat All" policy, have accompanied an increase in the number of patients with pretreatment HIV drug resistance (PDR) in the country. However, the scale of this public health problem is not well established. The objective of this study was to estimate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Reverse Transcriptase Inhibitors

Share to Trinidad and Tobago

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 37409403
DOI: 10.1089/AID.2022.0155
PMCID: PMC11040187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Burden of Pretreatment HIV Drug Resistance in Trinidad and Tobago.PMID 37409403Read ↗

HIV drug resistance in persons initiating or reinitiating first‐line antiretroviral therapy in Paraguay: Results of a National Patient SurveySemantic proximity Read ↗

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.Semantic proximity Read ↗

Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China.Semantic proximity Read ↗

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.Semantic proximity Read ↗

HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010-2013.Semantic proximity Read ↗

Pretreatment HIV drug resistance among adults initiating ART in Namibia.Semantic proximity Read ↗

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Semantic proximity Read ↗

National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing.Semantic proximity Read ↗

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase.Semantic proximity Read ↗

HIV Dolutegravir Resistance and Multiclass Failure in Mozambique: Findings from a Real-World CohortSemantic proximity Read ↗

HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.